Skim the headlines, and you might get the impression that the biotech startup world revolves around an insider’s club of Midas-listed venture capitalists.
Not true.
Clever entrepreneurs who know where to look can find other sources who bring a lot to the table – family offices, venture philanthropies, crossover funds, and corporate investors. Billions of dollars are available from non-traditional sources that don’t exactly advertise that fact. Some of them start investing as early as Series A and have the deep pockets to go much further.
